Although no studies have yet explored the consequences of disrupted cardiac ATG7 expression, familial ATG5 mutations are associated with severe cardiac hypertrophy leading to dilated cardiomyopathy by 10 months [55]. Here, ATG5 is linked to cardiac hypertrophy.